Collectively, our work provides a possible explanation for the reported cellular and systemic defects caused by loss of Caspase-2, including increased aneuploidy and heightened tumor susceptibility upon oncogenic stress, metabolic dysfunction, or proteotoxic stress and premature aging. This evidence concerns the gene CASP2 and neoplasm.